This case is reserved for use by Columbia Business School Faculty only.
Should a private equity firm invest in healthcare start-up Twistle, and if so, at what valuation and terms?
Should a private equity firm invest in healthcare start-up Twistle, and if so, at what valuation and terms?
Kulmeet Singh, serial healthcare entrepreneur, co-founded Twistle with Harjinder Sandhu, with the idea of transforming the healthcare experience for both patients and physicians as they saw grave inefficiencies and poor support on both sides. Ultimately, the partners created a scalable engagement platform for the automation of communications among care teams and patients as well as a configurable dashboard for education and information sharing. As the company grew, earning its place as a unique comprehensive patient-focused platform, its growth attracted new forms of capital, which Twistle began to consider to further bolster its large-scale strategy. Health Enterprise Partners (HEP) was one such capital partner. In this case, students will step into the shoes of HEP investors as they learn about the digital healthcare industry and consider the risks, benefits and valuation of an investment in Twistle.
About the Author(s)
